Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CANAGLIFLOZIN Cause Cerebral infarction? 90 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 90 reports of Cerebral infarction have been filed in association with CANAGLIFLOZIN (INVOKANA). This represents 0.4% of all adverse event reports for CANAGLIFLOZIN.

90
Reports of Cerebral infarction with CANAGLIFLOZIN
0.4%
of all CANAGLIFLOZIN reports
8
Deaths
59
Hospitalizations

How Dangerous Is Cerebral infarction From CANAGLIFLOZIN?

Of the 90 reports, 8 (8.9%) resulted in death, 59 (65.6%) required hospitalization, and 10 (11.1%) were considered life-threatening.

Is Cerebral infarction Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CANAGLIFLOZIN. However, 90 reports have been filed with the FAERS database.

What Other Side Effects Does CANAGLIFLOZIN Cause?

Diabetic ketoacidosis (3,413) Toe amputation (2,193) Osteomyelitis (2,146) Acute kidney injury (1,853) Fungal infection (1,385) Gangrene (1,081) Weight decreased (1,014) Cellulitis (1,007) Urinary tract infection (920) Diabetic foot infection (832)

What Other Drugs Cause Cerebral infarction?

RIVAROXABAN (1,367) APIXABAN (937) DABIGATRAN ETEXILATE (713) ASPIRIN (535) EDOXABAN (419) CLOPIDOGREL BISULFATE (315) PEMBROLIZUMAB (295) BEVACIZUMAB (269) METHOTREXATE (265) NIVOLUMAB (262)

Which CANAGLIFLOZIN Alternatives Have Lower Cerebral infarction Risk?

CANAGLIFLOZIN vs CANAGLIFLOZIN\METFORMIN CANAGLIFLOZIN vs CANAKINUMAB CANAGLIFLOZIN vs CANDESARTAN CANAGLIFLOZIN vs CANDESARTAN CILEXETIL CANAGLIFLOZIN vs CANDESARTAN CILEXETIL\HYDROCHLOROTHIAZIDE

Related Pages

CANAGLIFLOZIN Full Profile All Cerebral infarction Reports All Drugs Causing Cerebral infarction CANAGLIFLOZIN Demographics